Guide · updated 16 May 2026

Insulin resistance and PCOS / PMOS

Insulin resistance is not a side detail of PCOS — it is one of its central mechanisms, present in 30–80% of patients depending on the measurement method used — including up to 75% of lean women. It is precisely the M in PMOS (Metabolic) that was placed at the heart of the syndrome's new name.

Information, not a diagnosis. This page provides general guidance. It does not constitute a diagnosis and does not replace a personalised medical consultation.

What is insulin resistance?

Insulin is a hormone produced by the pancreas whose role is to allow glucose (sugar) to enter cells to be used as energy. When cells become less sensitive to insulin, the pancreas must produce more of it to achieve the same effect — that is insulin resistance (IR).

Over time, this excess circulating insulin (hyperinsulinaemia) creates cascading effects: it stimulates androgen production by the ovaries and adrenal glands, disrupts follicular maturation, promotes weight gain (particularly abdominal), and increases the risk of type 2 diabetes and cardiovascular disease. In PCOS, this vicious cycle can sustain and worsen the full range of symptoms.

Why are PCOS and insulin resistance linked?

The link is not incidental: insulin resistance is an intrinsic feature of PCOS, present even in normal-weight patients. This is what the renaming to PMOS underlines: including Metabolic in the acronym acknowledges that the syndrome is partly a metabolic condition, not just gynaecological or hormonal in the narrow sense.

Excess insulin directly stimulates ovarian theca cells to produce more androgens. These additional androgens disrupt follicular maturation (anovulation), worsen acne and hirsutism, and reinforce insulin resistance through further mechanisms. This forms a loop that needs to be understood — and interrupted, where possible, at multiple levels simultaneously.

How does insulin resistance present?

Clinical signs can point toward insulin resistance, but are insufficient for diagnosis:

Fatigue after meals, particularly carbohydrate-rich meals — the body “over-reacts” with an exaggerated insulin response, then blood glucose drops.
Sugar cravings, often 2–3 hours after a meal, linked to this glycaemic instability.
Difficulty losing weight, especially in the abdominal area, even with a balanced diet and physical activity.
Acanthosis nigricans: dark, velvety patches of skin at the neck, armpits or groin — a cutaneous sign of hyperinsulinaemia, often subtle but specific.

These signs indicate a metabolic component worth investigating. They cannot be conclusive on their own — a blood test is necessary.

What tests may be discussed with your doctor?

Several tests allow assessment of metabolic status in PCOS. They are prescribed and interpreted in clinical context:

Fasting glucose: first indicator of glucose tolerance. A value between 5.6–6.9 mmol/L (100–125 mg/dL) suggests impaired fasting glucose without diabetes.
HbA1c (glycated haemoglobin): reflects blood glucose over the past 3 months. More stable than a single glucose reading.
Fasting insulin: measured alongside glucose, it allows calculation of HOMA-IR. Depending on clinician and country, this test is not always routinely ordered.
HOMA-IR: index calculated by the formula (glucose mmol/L × insulin µU/mL) / 22.5. A score above 2.5–3 is often used as a threshold for concern, but reference values vary by laboratory and guidelines. The Monash 2023 guideline highlights these interpretation limitations.
Oral glucose tolerance test (OGTT): a 2-hour glucose tolerance test, indicated in certain contexts to screen for subclinical intolerance or early type 2 diabetes.

You can calculate your HOMA-IR score with our cautious calculator — or prepare your appointment to discuss this workup with your doctor.

What are the long-term risks?

The NIH / NICHD and the WHO document increased metabolic and cardiovascular risks in PCOS, notably linked to chronic insulin resistance. The main ones:

Type 2 diabetes: risk 3 to 5 times higher than in the general population. Regular screening (fasting glucose, HbA1c) is recommended, even in young patients without excess weight.
Metabolic syndrome: a cluster of cardiovascular risk factors (high waist circumference, high blood pressure, elevated glucose, low HDL, elevated triglycerides).
Cardiovascular disease: risk is increased, particularly after menopause. Monitoring blood pressure, lipid panel, and glucose is especially important in the long term.

None of these risks are inevitable. They can be managed with appropriate follow-up and sustained lifestyle habits.

What to do: three levels of action

1. Lifestyle — without dieting, without restriction

What is documented to improve insulin sensitivity in PCOS is not a specific diet — it is consistency. Regular mealtimes, a satisfying diet (with fibre, protein, quality fats), regular moderate physical activity (30 minutes of daily walking often beats one intense session per week), and sufficient quality sleep.

Physical activity improves glucose uptake by muscles independently of insulin — this is a powerful, accessible, and well-validated mechanism. It does not need to be intense to be effective.

2. Medical treatment when indicated

Metformin is the most studied treatment for insulin resistance in PCOS. It improves insulin sensitivity, can reduce circulating androgens, and may improve cycle regularity in certain patients. It is prescribed for specific indications — not routinely for all women with PCOS — and requires monitoring (kidney function, digestive tolerance). The decision belongs to your doctor.

3. Supplements — with caution

Inositol (myo-inositol, D-chiro-inositol) is frequently mentioned in the context of PCOS. Studies show moderate effects on glycaemia, insulin, and some hormonal parameters — but the level of evidence remains limited, and studies are often short and small. It is not a substitute for medical treatment, and its effects are not predictable from person to person. Discuss it with your doctor if you are considering it.

What about weight?

This is the most sensitive question, and it deserves a clear answer. In patients with overweight, a 5–10% reduction in body weight can improve insulin sensitivity, reduce androgens, and improve cycle regularity — documented by the Monash 2023 guideline .

But several important points are worth stating clearly:

This does not apply to everyone. A significant proportion of women with PCOS have a normal or low weight, and insulin resistance can be present in them too.
Weight is not a moral parameter. Guilt around weight increases anxiety, encourages disordered eating, and is medically counterproductive.
If weight loss is medically relevant in your situation, it is something to discuss with your doctor and, ideally, a registered dietitian — never alone, never through severe restriction.

When to seek medical attention sooner?

Some signs warrant not waiting for the next scheduled appointment: unusual persistent fatigue despite sufficient sleep, intense thirst, recurrent infections (skin, urinary, yeast), rapid unexplained weight gain or loss. These signals may indicate a change in your glycaemic profile that needs reassessment.

Prepare my metabolic appointment Questions for my doctor (insulin focus)HOMA-IR calculator

Frequently asked questions

Does insulin resistance affect lean women with PCOS too?

Yes. This is one of the most persistent misconceptions. Insulin resistance is present in 30–75% of women with PCOS who have a normal weight, according to studies. It is not a consequence of excess weight — it is an intrinsic mechanism of the syndrome, present across all body types.

Is HOMA-IR sufficient to diagnose insulin resistance?

No. HOMA-IR is one indicator among others, calculated from fasting glucose and fasting insulin. Its thresholds vary by laboratory, assay method, and study population. A result must be interpreted in its clinical context by a doctor — it cannot be read in isolation.

Should everyone with PCOS take metformin?

No. Metformin is a medical option in certain PCOS indications (documented insulin resistance, impaired glucose tolerance, certain cases of infertility), but it is not a universal treatment. The decision to prescribe it — or not — belongs to your doctor, based on your profile, your workup and your goals.

Will a strict or sugar-free diet improve my PCOS?

No restrictive diet constitutes a treatment for PCOS. Very restrictive approaches (ketogenic, prolonged fasting, total carbohydrate elimination) can create other imbalances and are often hard to sustain. What is documented: regular meals, a satisfying diet rich in fibre and protein, and regular moderate physical activity. Consistency matters more than restriction.

Does inositol really work?

Studies on myo-inositol and D-chiro-inositol show moderate effects on insulin sensitivity, cycle regularity and some hormonal parameters in certain patients. The level of evidence remains limited (often small, heterogeneous studies). It is an option to discuss with your doctor — not a certain solution or an alternative to validated medical treatments.

How long before I see improvements in metabolic parameters?

With consistent, sustained lifestyle changes, the first improvements (blood glucose, insulin, cycle regularity) are generally seen after 3 to 6 months. With metformin, effects develop over the same timeframe. Patience and consistency count more than intensity of effort.

Main sources

Page written from official public sources. It is not intended to diagnose or recommend a treatment. For any medical decision, consult a healthcare professional.